A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (Paperback)
Institute of Medicine, National Research Council, Division on Earth and Life Studies, Board on Environmental Studies and Toxicology, Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II
Ships in 12 - 17 working days